These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6372924)

  • 1. Clinical effects of apomorphine in schizophrenia.
    Ferrier IN; Johnstone EC; Crow TJ
    Br J Psychiatry; 1984 Apr; 144():341-8. PubMed ID: 6372924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormonal effects of apomorphine in schizophrenia.
    Ferrier IN; Johnstone EC; Crow TJ
    Br J Psychiatry; 1984 Apr; 144():349-57. PubMed ID: 6722395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of intravenous and subcutaneous administration of apomorphine on the clinical symptoms of chronic schizophrenics.
    Syvälahti EK; Säkö E; Scheinin M; Pihlajamäki K; Hietala J
    Br J Psychiatry; 1986 Feb; 148():204-8. PubMed ID: 3516291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenic symptoms improve with apomorphine.
    Tamminga CA; Schaffer MH; Smith RC; Davis JM
    Science; 1978 May; 200(4341):567-8. PubMed ID: 347574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of dopamine agonists in the treatment of schizophrenia.
    Corsini GU; Pitzalis GF; Bernardi F; Bocchetta A; Del Zompo M
    Neuropharmacology; 1981 Dec; 20(12B):1309-13. PubMed ID: 7033816
    [No Abstract]   [Full Text] [Related]  

  • 6. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses.
    Levy MI; Davis BM; Mohs RC; Kendler KS; Mathé AA; Trigos G; Horvath TB; Davis KL
    Arch Gen Psychiatry; 1984 May; 41(5):520-4. PubMed ID: 6372737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of apomorphine on schizophrenic symptoms.
    Smith RC; Tamminga C; Davis JM
    J Neural Transm; 1977; 40(2):171-6. PubMed ID: 323423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apomorphine response and subtyping of schizophrenia.
    Jeste DV; Zalcman S; Weinberger DR; Cutler NR; Bigelow LB; Kleinman JE; Rogol A; Wyatt RJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):83-8. PubMed ID: 6682989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?
    Dépatie L; Lal S
    J Psychiatry Neurosci; 2001 May; 26(3):203-20. PubMed ID: 11394190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apomorphine and psychopathology.
    Lal S; De la Vega CE
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):722-6. PubMed ID: 1099172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of levodopa and apomorphine on blink reflex recovery cycle in essential blepharospasm.
    Napolitano A; Bonuccelli U; Rossi B
    Eur Neurol; 1997; 38(2):119-22. PubMed ID: 9286635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye-blinking and cerebral ventricular size in chronic schizophrenic patients.
    Kleinman JE; Karson CN; Weinberger DR; Freed WJ; Berman KF; Wyatt RJ
    Am J Psychiatry; 1984 Nov; 141(11):1430-2. PubMed ID: 6149700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia.
    Fletcher PC; Frith CD; Grasby PM; Friston KJ; Dolan RJ
    J Neurosci; 1996 Nov; 16(21):7055-62. PubMed ID: 8824341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apomorphine reduces schizophrenic symptoms.
    Schaffer MH; Tamminga CA; Smith RC; Davis JM
    Psychopharmacol Bull; 1980 Jan; 16(1):55-7. PubMed ID: 6987694
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of prolactin by dopamine agonists in schizophrenics and controls.
    Rotrosen J; Angrist B; Clark C; Gershon S; Halpers FS; Sachar EJ
    Am J Psychiatry; 1978 Aug; 135(8):949-51. PubMed ID: 665840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine effects of apomorphine: characterization of response patterns and application to schizophrenia research.
    Rotrosen J; Angrist B; Gershon S; Paquin J; Branchey L; Oleshansky M; Halpern F; Sachar EJ
    Br J Psychiatry; 1979 Nov; 135():444-56. PubMed ID: 540209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Apomorphine in dyskinesia and psychomotor agitation].
    Stoliarov GV; Markova OF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(8):97-102. PubMed ID: 7136384
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in blink rates of Nigerian schizophrenics treated with chlorpromazine.
    Adamson TA
    West Afr J Med; 1995; 14(4):194-7. PubMed ID: 8634222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated response of growth hormone to graded doses of apomorphine in schizophrenic patients.
    Müller-Spahn F; Modell S; Ackenheil M; Brachner A; Kurtz G
    J Psychiatr Res; 1998; 32(5):265-71. PubMed ID: 9789204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol-induced changes in blink rates correlate with changes in BPRS score.
    Karson CN; Bigelow LB; Kleinman JE; Weinberger DR; Wyatt RJ
    Br J Psychiatry; 1982 May; 140():503-7. PubMed ID: 7104533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.